CDK5 and prostate cancer: In prostate cancer cells, Cdk5 promotes cell growth in an androgen receptor (AR)- independent way and maintains high AKT kinase activity, which is known to correlate with prostate cancer progression and considered as a critical growth-promoting pathway in prostate cancer cells [68].